Presymptomatic genetic testing for neurodegenerative diseases can help patients make effective treatment decisions, but the medical profession needs to ensure that the increasing use of the tests is done responsibly.
The case of Nancy Cruzan, a 25-year-old woman whose injuries from an automobile accident resulted in a persistent vegetative state, helped to empower people with end-of-life choices.